M50I (p.Met50Ile) variant of CD2 (T-cell surface antigen CD2)
M50I (p.Met50Ile) in CD2 (T-cell surface antigen CD2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.14 / 1. The record also includes population frequency data and structural context.
M50I (p.Met50Ile) variant details
- p.Met50Ile
- NCI-TCGA Cosmic COSV6564
- cosmic curated COSV65643
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.142
- REVEL 0.08
- MetaLR 0.09
- MetaSVM -0.98
- CADD 6.55
- PolyPhen-2 0.20
- SIFT 0.09
- UniProt: Variant assessed as somatic; moderate impact.
- Most common in the Non-Finnish European population (allele frequency 9e-07)
- Structural context available